Key Details
Price
$1.73Annual ROE
518.49%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 10, 2024Recent annual earnings:
Mar 16, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jan 8, 2024Analyst ratings
Recent major analysts updates
Aug 29, 23 Citigroup
BuyJun 30, 23 Baird
OutperformSep 7, 22 BTIG
BuyAug 9, 21 Citigroup
BuyApr 3, 20 Wedbush
OutperformJan 22, 20 Ladenburg Thalmann
BuyJun 26, 19 Citigroup
BuyJan 29, 19 Baird
OutperformMay 17, 18 BTIG Research
BuyMay 17, 18 BTIG
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Eiger BioPharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Eiger BioPharmaceuticals?
- Does Eiger BioPharmaceuticals pay dividends?
- What sector is Eiger BioPharmaceuticals in?
- What industry is Eiger BioPharmaceuticals in?
- What country is Eiger BioPharmaceuticals based in?
- When did Eiger BioPharmaceuticals go public?
- Is Eiger BioPharmaceuticals in the S&P 500?
- Is Eiger BioPharmaceuticals in the NASDAQ 100?
- Is Eiger BioPharmaceuticals in the Dow Jones?
- When was Eiger BioPharmaceuticals's last earnings report?
- When does Eiger BioPharmaceuticals report earnings?
- Should I buy Eiger BioPharmaceuticals stock now?
What is the ticker symbol for Eiger BioPharmaceuticals?
The ticker symbol for Eiger BioPharmaceuticals is NASDAQ:EIGR
Does Eiger BioPharmaceuticals pay dividends?
No, Eiger BioPharmaceuticals does not pay dividends
What sector is Eiger BioPharmaceuticals in?
Eiger BioPharmaceuticals is in the Healthcare sector
What industry is Eiger BioPharmaceuticals in?
Eiger BioPharmaceuticals is in the Biotechnology industry
What country is Eiger BioPharmaceuticals based in?
Eiger BioPharmaceuticals is headquartered in United States
When did Eiger BioPharmaceuticals go public?
Eiger BioPharmaceuticals's initial public offering (IPO) was on January 30, 2014
Is Eiger BioPharmaceuticals in the S&P 500?
No, Eiger BioPharmaceuticals is not included in the S&P 500 index
Is Eiger BioPharmaceuticals in the NASDAQ 100?
No, Eiger BioPharmaceuticals is not included in the NASDAQ 100 index
Is Eiger BioPharmaceuticals in the Dow Jones?
No, Eiger BioPharmaceuticals is not included in the Dow Jones index
When was Eiger BioPharmaceuticals's last earnings report?
Eiger BioPharmaceuticals's most recent earnings report was on May 10, 2024
When does Eiger BioPharmaceuticals report earnings?
The date for Eiger BioPharmaceuticals's next earnings report has not been announced yet
Should I buy Eiger BioPharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions